Amanote Research
Register
Sign In
Pro Labeling in Products Approved by the European Medicines Agency (EMA) for Narcolepsy
Value in Health
- United Kingdom
doi 10.1016/j.jval.2017.08.1968
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2017
Authors
L Perrier
D Jurado
C Anfray
C Acquadro
Publisher
Elsevier BV
Related search
Pcn22 - Marketing Authorisation Practice of the European Medicines Agency (Ema) in Oncological Indications
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
What Is the European Medicines Agency?
Epidemiology and Psychiatric Sciences
Mental Health
Epidemiology
Public Health
Environmental
Psychiatry
Occupational Health
Is European Medicines Agency (EMA) Sepsis Criteria Accurate for Neonatal Sepsis Diagnosis or Do We Need New Criteria?
PLoS ONE
Multidisciplinary
Php31 - Impact of European Medicines Agency (Ema) Clinical Trial Transparency Policies on Health Technology Assessment (Hta) Decisions in Germany
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
FDA Reform and the European Medicines Evaluation Agency
Harvard Law Review
Law
The European Medicines Agency Facilitates Access to Medicines in Low- And Middle-Income Countries
Expert Review of Clinical Pharmacology
Medicine
Toxicology
Pharmaceutics
Pharmacology
European Medicines Agency Policies for Clinical Trials Leave Women Unprotected
Journal of Epidemiology and Community Health
Epidemiology
Public Health
Occupational Health
Environmental
European Medicines Agency Workshop on Biosimilar Monoclonal Antibodies
mAbs
Allergy
Immunology
Improving Risk Assessment in the European Food Safety Authority: Lessons From the European Medicines Agency
Frontiers in Plant Science
Plant Science
